Identifying high-risk groups for adverse outcomes after conization is crucial for developing targeted treatment plans for patients with cervical adenocarcinoma in situ (ACIS).
This study aimed to analyze the clinical characteristics of patients with ACIS and identify risk factors associated with adverse outcomes.
